The pharmaceutical landscape for blood sugar is shifting, and transdermal GLP-1 delivery systems represent a potential advance. Unlike injections, this approach offers a simpler way to provide GLP-1 drugs. These https://alyshakbuw675618.blogars.com/39476062/glp-1-patches-a-novel-approach-to-diabetes-treatment